A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal Nerves

Launched by ATRICURE, INC. · Oct 28, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a treatment called cryoablation, which involves using cold to numb specific nerves in the chest area, to help manage pain after surgery. The goal is to collect information from patients who have either undergone this procedure or are scheduled to do so, to see how well it works in relieving post-operative pain.

To be eligible for this study, participants need to be at least 12 years old and able to give consent. They should be scheduled for cryoablation of the intercostal nerves or have had similar treatments without this specific method. Participants can expect to share their experiences and outcomes related to pain management during and after the treatment. It’s important to note that individuals who are pregnant or planning to become pregnant, as well as those involved in other trials that might conflict with this study, cannot participate. This research aims to improve pain management options for patients after surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients whose age is 12 years or above, and are able to give informed consent/assent specific to state and national law.
• • 2. Patients have been scheduled by physician(s) to undergo or have undergone cryoablation of the intercostal nerves utilizing at least one AtriCure device or are similar patients treated without the use of cryoablation
• Exclusion Criteria:
• • 1. Patient is enrolled in a concurrent trial that may impact the treatment offered by the registry devices.
• • 2. Patient with exclusion criteria required by local governance.
• • 3. Women of childbearing potential who are, or plan to become, pregnant during the time of the study